Vibram USA Inc. has agreed to settle for $3.75 million a class action that challenged as wholly misleading the company’s marketing claims that running in its FiveFingers footwear brings an array of health benefits, including a reduced risk of injury.
Vibram’s advertising for the “minimalist” shoes, which can cost $125 and look like thin-soled foot gloves, touted the footwear as a way to strengthen muscles, promote spine alignment, stimulate neural function, reduce lower back pain and improve foot health. Promoting the shoes as providing the benefits of running barefoot without the risks, the company claims its pitches are backed up by scientific research.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
